Literature DB >> 25644916

A 60-year-old asymptomatic woman with pulmonary lesions and cervical lymphadenopathy.

Tomoko Yamagishi1, Nobuaki Ochi1, Hiromichi Yamane1, Futoshi Kuribayashi2, Nagio Takigawa3.   

Abstract

A 60-year-old asymptomatic woman was referred to our hospital because of an abnormal chest roentgenogram during a routine medical checkup. The patient had no history of memorable infectious diseases, except a liver abscess caused by Serratia marcescens at age 46 years. Her son was diagnosed with chronic granulomatous disease at the age of 1 year. She had never smoked cigarettes and drank only occasionally.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25644916      PMCID： PMC4314823          DOI： 10.1378/chest.14-1215

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


  10 in total

Review 1.  Chronic granulomatous disease: lessons from a rare disorder.

Authors:  Brahm H Segal; Paul Veys; Harry Malech; Morton J Cowan
Journal:  Biol Blood Marrow Transplant       Date:  2011-01       Impact factor: 5.742

Review 2.  Chronic granulomatous disease.

Authors:  Alexander J Towbin; Ian Chaves
Journal:  Pediatr Radiol       Date:  2010-02-05

Review 3.  Molecular diagnosis of chronic granulomatous disease.

Authors:  D Roos; M de Boer
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

4.  Increased susceptibility of a carrier of X-linked chronic granulomatous disease (CGD) to Aspergillus fumigatus infection associated with age-related skewing of lyonization.

Authors:  A Rösen-Wolff; W Soldan; K Heyne; J Bickhardt; M Gahr; J Roesler
Journal:  Ann Hematol       Date:  2001-02       Impact factor: 3.673

5.  A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity.

Authors:  Juan D Matute; Andres A Arias; Nicola A M Wright; Iwona Wrobel; Christopher C M Waterhouse; Xing Jun Li; Christophe C Marchal; Natalie D Stull; David B Lewis; MacGregor Steele; James D Kellner; Weiming Yu; Samy O Meroueh; William M Nauseef; Mary C Dinauer
Journal:  Blood       Date:  2009-08-19       Impact factor: 22.113

Review 6.  Modern management of chronic granulomatous disease.

Authors:  Reinhard A Seger
Journal:  Br J Haematol       Date:  2008-02       Impact factor: 6.998

7.  Gastrointestinal involvement in chronic granulomatous disease.

Authors:  Beatriz E Marciano; Sergio D Rosenzweig; David E Kleiner; Victoria L Anderson; Dirk N Darnell; Sandra Anaya-O'Brien; Dianne M Hilligoss; Harry L Malech; John I Gallin; Steven M Holland
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

Review 8.  Pulmonary manifestations of chronic granulomatous disease.

Authors:  Seyed Alireza Mahdaviani; Seyed Amir Mohajerani; Nima Rezaei; Jean-Laurent Casanova; Seyed Davood Mansouri; Ali Akbar Velayati
Journal:  Expert Rev Clin Immunol       Date:  2013-02       Impact factor: 4.473

9.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

Review 10.  Aspergillus nidulans infection in chronic granulomatous disease.

Authors:  B H Segal; E S DeCarlo; K J Kwon-Chung; H L Malech; J I Gallin; S M Holland
Journal:  Medicine (Baltimore)       Date:  1998-09       Impact factor: 1.889
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.